our portfolio
Tools for Drug Discovery
Products, instruments, and services all geared towards mimicking native conditions to provide more biologically relevant data.
SARS-CoV-2 Products
Discover the safe SARS-CoV-2 Lentivirus vector and the first to market COVID-19 ELISA test to replace PRNT testing.
